GE HealthCare Files 8-K on Agreements and Obligations

Ticker: GEHC · Form: 8-K · Filed: 2025-03-31T00:00:00.000Z

Sentiment: neutral

Topics: material-agreement, financial-obligation, 8-k

Related Tickers: GEHC

TL;DR

GE HealthCare signed and terminated a deal, plus took on new debt. Check the filings.

AI Summary

GE HealthCare Technologies Inc. filed an 8-K on March 27, 2025, reporting the entry into and termination of a material definitive agreement, as well as the creation of a direct financial obligation. The filing also includes financial statements and exhibits.

Why It Matters

This filing indicates significant changes in GE HealthCare's contractual and financial commitments, which could impact its future operations and financial health.

Risk Assessment

Risk Level: medium — The termination of a material definitive agreement and the creation of a new financial obligation suggest potential shifts in the company's strategic or financial landscape that warrant closer examination.

Key Players & Entities

FAQ

What was the nature of the material definitive agreement that was entered into and subsequently terminated?

The filing does not specify the nature of the agreement, only that it was a material definitive agreement that was both entered into and terminated.

What is the nature of the direct financial obligation created by GE HealthCare Technologies Inc.?

The filing indicates the creation of a direct financial obligation but does not provide specific details about its terms or amount.

When was the earliest event reported in this 8-K filing?

The earliest event reported was on March 27, 2025.

What is the principal executive office address for GE HealthCare Technologies Inc.?

The principal executive office is located at 500 W. Monroe Street, Chicago, IL 60661.

What is the SIC code for GE HealthCare Technologies Inc.?

The SIC code is 3844, which corresponds to X-RAY APPARATUS & TUBES & RELATED IRRADIATION APPARATUS.

From the Filing

0001932393-25-000007.txt : 20250331 0001932393-25-000007.hdr.sgml : 20250331 20250331170951 ACCESSION NUMBER: 0001932393-25-000007 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 15 CONFORMED PERIOD OF REPORT: 20250327 ITEM INFORMATION: Entry into a Material Definitive Agreement ITEM INFORMATION: Termination of a Material Definitive Agreement ITEM INFORMATION: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20250331 DATE AS OF CHANGE: 20250331 FILER: COMPANY DATA: COMPANY CONFORMED NAME: GE HealthCare Technologies Inc. CENTRAL INDEX KEY: 0001932393 STANDARD INDUSTRIAL CLASSIFICATION: X-RAY APPARATUS & TUBES & RELATED IRRADIATION APPARATUS [3844] ORGANIZATION NAME: 08 Industrial Applications and Services EIN: 882515116 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-41528 FILM NUMBER: 25794853 BUSINESS ADDRESS: STREET 1: 500 WEST MONROE STREET CITY: CHICAGO STATE: IL ZIP: 60661 BUSINESS PHONE: 833-735-1139 MAIL ADDRESS: STREET 1: 500 WEST MONROE STREET CITY: CHICAGO STATE: IL ZIP: 60661 FORMER COMPANY: FORMER CONFORMED NAME: GE Healthcare Holding LLC DATE OF NAME CHANGE: 20220603 8-K 1 gehc-20250327.htm 8-K gehc-20250327 0001932393 false 0001932393 2025-03-27 2025-03-27 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) March 27, 2025 GE HEALTHCARE TECHNOLOGIES INC. (Exact name of registrant as specified in its charter)   Delaware 001-41528 88-2515116 (State or other jurisdiction of incorporation) (Commission  File Number) (IRS Employer Identification No.)       500 W. Monroe Street, Chicago, IL   60661 (Address of principal executive offices)   (Zip Code)         (Registrant’s telephone number, including area code) ( 833 ) 735-1139 ______________________________________________ (Former name or former address, if changed since last report.) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instructions A.2. below): ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)  ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading Symbol(s) Name of each exchange on which registered Common stock, par value $0.01 per share GEHC The Nasdaq Stock Market LLC Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter). Emerging growth company ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards pursuant to Section 13(a) of the Exchange Act. ☐ Item 1.01 Entry into a Material Definitive Agreement. On March 27, 2025, GE HealthCare Technologies Inc. (the “Company”) entered into (i) a 364-Day Revolving Credit Agreement (the “2025 364-Day Revolving Credit Agreement”) among the Company, JPMorgan Chase Bank, N.A., as administrative agent, and the lenders named therein, which provides for a 364-day senior unsecured revolving credit fac

View on Read The Filing